FRM-0334 for Frontotemporal Dementia with a Granulin Mutation

Language Undefined Purpose: To investigate the safety, tolerability, and pharmacodynamics of the experimental drug FRM-0334 in people with early to moderate frontotemporal dementia with a granulin mutation.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: Source Type: clinical trials